中国血液流变学杂志
中國血液流變學雜誌
중국혈액류변학잡지
CHINESE JOURNAL OF HEMORHEOLOGY
2001年
2期
118-120
,共3页
高镇松%陈政雄%李植荣%林和文%吴树跃%郭婵娥
高鎮鬆%陳政雄%李植榮%林和文%吳樹躍%郭嬋娥
고진송%진정웅%리식영%림화문%오수약%곽선아
复方丹参%精神分裂%辅助治疗作用%血液流变学
複方丹參%精神分裂%輔助治療作用%血液流變學
복방단삼%정신분렬%보조치료작용%혈액류변학
目的从血液流变学角度探讨复方丹参对精神分裂症的辅助治病作用。方法对符合CCMD-2-R精神分裂症诊断标准的120例患者进行分组治疗,研究组30例以抗精神病药加复方丹参,对照组90例单以抗精神病药治疗,观察4周,分别于治疗前和4周后检则血液流变学12项指标和简明精神病量表(BPRS)总分。结果研究组治疗4周后的全血粘度(300s-1和1.0s-1、低切还原粘度、RBC刚性指数、RBC聚集指数和纤维蛋白原都显著低于治疗前且都显著低于对照组(P<0.05~0.01),脑血流量则显著高于治疗前(P<0.05);而对照组除全血粘度有显著改善外其它指标在治疗前后无显著性差异(P>0.05)。研究组治疗4周后的BPRS减分率显著高于对照组(P<0.01)。结论复方丹参对精神分裂症有辅助治疗作用,能改善精神分裂症的高粘滞血症和提高BPRS减分率。
目的從血液流變學角度探討複方丹參對精神分裂癥的輔助治病作用。方法對符閤CCMD-2-R精神分裂癥診斷標準的120例患者進行分組治療,研究組30例以抗精神病藥加複方丹參,對照組90例單以抗精神病藥治療,觀察4週,分彆于治療前和4週後檢則血液流變學12項指標和簡明精神病量錶(BPRS)總分。結果研究組治療4週後的全血粘度(300s-1和1.0s-1、低切還原粘度、RBC剛性指數、RBC聚集指數和纖維蛋白原都顯著低于治療前且都顯著低于對照組(P<0.05~0.01),腦血流量則顯著高于治療前(P<0.05);而對照組除全血粘度有顯著改善外其它指標在治療前後無顯著性差異(P>0.05)。研究組治療4週後的BPRS減分率顯著高于對照組(P<0.01)。結論複方丹參對精神分裂癥有輔助治療作用,能改善精神分裂癥的高粘滯血癥和提高BPRS減分率。
목적종혈액류변학각도탐토복방단삼대정신분렬증적보조치병작용。방법대부합CCMD-2-R정신분렬증진단표준적120례환자진행분조치료,연구조30례이항정신병약가복방단삼,대조조90례단이항정신병약치료,관찰4주,분별우치료전화4주후검칙혈액류변학12항지표화간명정신병량표(BPRS)총분。결과연구조치료4주후적전혈점도(300s-1화1.0s-1、저절환원점도、RBC강성지수、RBC취집지수화섬유단백원도현저저우치료전차도현저저우대조조(P<0.05~0.01),뇌혈류량칙현저고우치료전(P<0.05);이대조조제전혈점도유현저개선외기타지표재치료전후무현저성차이(P>0.05)。연구조치료4주후적BPRS감분솔현저고우대조조(P<0.01)。결론복방단삼대정신분렬증유보조치료작용,능개선정신분렬증적고점체혈증화제고BPRS감분솔。
Objective To explore the adjunct effects of Radix Salviae Miltorrhzae Compsita(RSMC) in the treatment of schizophrenia on hemorheology. Method 120 cases with the diagnosis of schizophrenia according to CCMD-2-R were assigned into the tested(n=30) and control group(n=90). Patients in the tested group were treated with antipsychotic drugs and RSMC 3#, orally, tid; while subjects in the control group only with antipsychotic drugs, for the course of 4 weeks. The two group patients were respectively cheched up 12 hemorheological indices and Brief Psychiatric Rating Scale(BPRS) before and after 4 weeks of treatment. Results The whole blood viscosity (300s-1 and 1.0s-1), low shear reduction viscosity, red blood cell(RBC) stiffness index, RBC aggregation index and fibrinogen in the tested group after 4 weeks of treatment were significantly lower than that before treatment as well as in the control group (P<0.05 or 0.01); while cerebral blood flow showed significantly higher than that before treatment (P<0.05). The control group showed no sighificant difference (p>0.05) between before and after 4 weeks of treatment except the whole blood viscosity improvement (P<0.01). BPRS score reduced rate in the tested group after 4 weeks of treatment showed sighificantly higher than in the control. Conclusion There are adjunct effects of RSMC in the treatment of schizophrenia. RSMC can improve the hypervis-semia and increase BPRS score reduced rate in schizophrenia.